Search

Your search keyword '"Busby, John"' showing total 431 results

Search Constraints

Start Over You searched for: Author "Busby, John" Remove constraint Author: "Busby, John"
431 results on '"Busby, John"'

Search Results

3. Cognitive and psychiatric symptom trajectories 2–3 years after hospital admission for COVID-19: a longitudinal, prospective cohort study in the UK

4. Exploring Definitions and Predictors of Response to Biologics for Severe Asthma

6. International Variation in Severe Exacerbation Rates in Patients With Severe Asthma

8. Impact of pre-biologic impairment on meeting domain-specific biologic responder definitions in patients with severe asthma

11. Analysis of comorbidities and multimorbidity in adult patients in the International Severe Asthma Registry

12. Blood transcriptomic signature in type-2 biomarker-low severe asthma and asthma control

13. Impact of Initiating Biologics in Patients With Severe Asthma on Long-Term Oral Corticosteroids or Frequent Rescue Steroids (GLITTER): Data From the International Severe Asthma Registry

15. Orchid diversity and occurrence in relation to past fire in Canberra Nature Park

16. A Randomized Trial of a Composite T2-Biomarker Strategy Adjusting Corticosteroid Treatment in Severe Asthma: A Post Hoc Analysis by Sex

18. Global Variability in Administrative Approval Prescription Criteria for Biologic Therapy in Severe Asthma

19. Real‐world biologics response and super‐response in the International Severe Asthma Registry cohort.

20. Exploring Definitions and Predictors of Severe Asthma Clinical Remission after Biologic Treatment in Adults.

22. The inflammatory profile of exacerbations in patients with severe refractory eosinophilic asthma receiving mepolizumab (the MEX study): a prospective observational study

24. Potential Severe Asthma Hidden in UK Primary Care

25. Cognitive and psychiatric symptom trajectories 2–3 years after hospital admission for COVID-19: a longitudinal, prospective cohort study in the UK

26. Composite type-2 biomarker strategy versus a symptom–risk-based algorithm to adjust corticosteroid dose in patients with severe asthma: a multicentre, single-blind, parallel group, randomised controlled trial

27. Association between pre-biologic T2-biomarker combinations and response to biologics in patients with severe asthma

29. Characterization of Severe Asthma Worldwide: Data From the International Severe Asthma Registry

30. Reply to “Exploring the long-term effects of biologic initiation in severe asthma: Insights from the International Severe Asthma Registry”

32. Impact of pre-biologic impairment on meeting domain-specific biologic responder definitions in patients with severe asthma

34. Preventing unnecessary unplanned hospital admissions and achieving timely discharge; an analysis of geographic variation

35. Impact of sex on severe asthma: a cross-sectional retrospective analysis of UK primary and specialist care.

36. Association Between T2-related Comorbidities and Effectiveness of Biologics in Severe Asthma

38. Clinical remission in severe asthma with biologic therapy: an analysis from the UK Severe Asthma Registry

39. Adult Severe Asthma Registries: A Global and Growing Inventory

41. Clinical remission following biologic initiation in severe asthma: results of the International Severe Asthma Registry (ISAR)

42. Real-world associations between outcomes and biomarkers in severe asthma patients treated with biologics

45. Real world biologic treatment response in severe asthma: an analysis of the International Severe Asthma Registry (ISAR)

46. Urinary eicosanoids - novel biomarkers in T2-low severe asthma

47. Characteristics associated with clinical remission in patients with severe asthma who initiate biologics

Catalog

Books, media, physical & digital resources